Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-123P, or RNA, U6 small nuclear 123, pseudogene, is one of many annotated U6 snRNA-derived pseudogenes present throughout the human genome[4][5]. Unlike canonical U6 small nuclear RNAs, which play a central role in pre-mRNA splicing within the spliceosome[1][3], pseudogenes like RNU6-123P are generally non-functional, untranslated genomic elements arising from duplication or retrotransposition events[5]. They do not produce a functional RNA or protein, and no evidence links this specific pseudogene to any biological process, disease, or therapeutic mechanism[2][5]. The “U6” small nuclear RNA genes are required for proper function of the spliceosome, facilitating the excision of introns from pre-mRNA, but pseudogenes in this family, such as RNU6-123P, are not known to participate in these or any cellular processes[1][3][5]. The existence of numerous U6 pseudogenes in the genome is a feature of vertebrates and is generally considered to be evolutionary “background” rather than functionally significant[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 123, pseudogene (RNU6-123P).